The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients
Open accessAbstract
Besides being part of anti- Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However, little is known about the effects of PPIs on the human gastric microbiota, especially those related to H. pylori infection. The goal of this study was to characterize the stomach microbial communities in patients with dyspepsia and to investigate their relationships with PPI use and H. pylori status. Using 16S rRNA gene pyrosequencing, we analyzed the mucosa-associated microbial populations of 24 patients, of whom 12 were treated with the PPI omeprazole and 9 (5 treated and 4 untreated) were positive for H. pylori infection. The Proteobacteria , Firmicutes , Bacteroidetes , Fusobacteria , and Actinobacteria phyla accounted for 98% of all of the sequences, with Helicobacter , Streptococcus , and Prevotella ranking among the 10 most abundant genera. H. pylori infection or PPI treatment did not significantly influence gastric microbial species composition in dyspeptic patients. Principal-coordinate analysis of weighted UniFrac distances in these communities revealed clear but significant separation according to H. pylori status only. However, in PPI-treated patients, Firmicutes , particularly Streptococcaceae , were significantly increased in relative abundance compared to those in untreated patients. Consistently, Streptococcus was also found to significantly increase in relation to PPI treatment, and this increase seemed to occur independently of H. pylori infection. Our results suggest that Streptococcus may be a key indicator of PPI-induced gastric microbial composition changes in dyspeptic patients. Whether the gastric microbiota alteration contributes to dyspepsia needs further investigation. IMPORTANCE Although PPIs have become a popular treatment choice, a growing number of dyspeptic patients may be treated unnecessarily. We found that patients treated with omeprazole showed gastric microbial communities that were different from those of untreated patients. These differences regarded the abundances of specific taxa. By understanding the relationships between PPIs and members of the gastric microbiota, it will be possible to envisage new strategies for better managing patients with dyspepsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary abundance of Streptococcaceae was also demonstrated in dyspeptic patients during PPI treatment, suggesting that this ecological switch in favor of Streptococcaceae could be an independent indicator of gastric dysbiosis due to these drugs[59].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 21,098
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
PyNAST: a flexible tool for aligning sequences to a template alignment
Caporaso, J. G., Bittinger, K. L., Bushman, F. D., DeSantis, T. Z., Andersen, G. L., & Knight, R. D. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp636 · Cited by 3,449
THE POPULATION FREQUENCIES OF SPECIES AND THE ESTIMATION OF POPULATION PARAMETERS
Good, I. J. (1953) · Biometrika · doi:10.1093/biomet/40.3-4.237 · Cited by 3,427
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Mégraud, F., O'Morain, C. A., Atherton, J. C., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,346
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,599
UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context
Lozupone, C., Hamady, M., & Knight, R. D. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-371 · Cited by 1,454
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
Wong, B. C., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,436
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 1×
“Similarly, PPI use was shown to be associated with profound changes in the gut microbiota, involving the genera Streptococcus, Enterococcus, and Staphylococcus, and the species Escherichia coli (52).”
BackgroundError-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex
Hamady, M., Walker, J. J., Harris, J. K., Gold, N. J., & Knight, R. (2008) · Nature Methods · doi:10.1038/nmeth.1184 · Cited by 1,310
Molecular analysis of the bacterial microbiota in the human stomach
Bik, E. M., Eckburg, P. B., Gill, S. R., Nelson, K. E., Purdom, E. A., François, F., Perez-Perez, G., Blaser, M. J., & Relman, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506655103 · Cited by 1,160
Re-evaluating prokaryotic species
Gevers, D., Cohan, F. M., Lawrence, J. G., Spratt, B. G., Coenye, T., Feil, E. J., Stackebrandt, E. S., de Peer, Y. V., Vandamme, P. A. R., Thompson, F. L., et al. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1236 · Cited by 1,111
Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing
Andersson, A. F., Lindberg, M., Jakobsson, H. E., Bäckhed, F., Nyrén, P., & Engstrand, L. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002836 · Cited by 1,079
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895
Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions
Reeder, J., & Knight, R. D. (2010) · Nature Methods · doi:10.1038/nmeth0910-668b · Cited by 688
Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori
Salama, N. R., Hartung, M. L., & Mueller, A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3016 · Cited by 668
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
Atherton, J. C., & Blaser, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38605 · Cited by 549
Binladen, J., Gilbert, M. T. P., Bollback, J. P., Panitz, F., Bendixen, C., Nielsen, R., & Willerslev, E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000197 · Cited by 522
Gastro-oesophageal reflux disease
Moayyedi, P., & Talley, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68932-0 · Cited by 433
Bacterial biogeography of the human digestive tract
Stearns, J. C., Lynch, M. D. J., Senadheera, D. B., Tenenbaum, H. C., Goldberg, M. B., Cvitkovitch, D. G., Croitoru, K., Moreno‐Hagelsieb, G., & Neufeld, J. D. (2011) · Scientific Reports · doi:10.1038/srep00170 · Cited by 411
Canani, R. B., Cirillo, P., Roggero, P., Romano, C., Malamisura, B., Terrin, G., Passariello, A., Manguso, F., Morelli, L., Guarino, A., et al. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1655 · Cited by 395
Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences
Soergel, D. A. W., Dey, N., Knight, R. D., & Brenner, S. E. (2012) · The ISME Journal · doi:10.1038/ismej.2011.208 · Cited by 376
Use of Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia
Gülmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 342
Structure of the human gastric bacterial community in relation to Helicobacter pylori status
Maldonado‐Contreras, A., Goldfarb, K. C., Godoy‐Vitorino, F., Karaöz, U., Contreras, M., Blaser, M. J., Brodie, E., & Domínguez-Bello, M. G. (2010) · The ISME Journal · doi:10.1038/ismej.2010.149 · Cited by 311
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls
Dicksved, J., Lindberg, M., Rosenquist, M., Enroth, H., Jansson, J. K., & Engstrand, L. G. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.007302-0 · Cited by 307
Eun, C. S., Kim, B. K., Han, D. S., Kim, S., Kim, K. M., Choi, B. Y., Song, K. S., Kim, Y. S., & Kim, J. F. (2014) · Helicobacter · doi:10.1111/hel.12145 · Cited by 292
Gut microbiota, immune development and function
Bengmark, S. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.002 · Cited by 274
Li, X., Wong, G. L., To, K., Wong, V. W., Lai, L. H., Chow, D. K., Lau, J. Y. W., Sung, J. J. �., & Ding, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007985 · Cited by 258
Microbiological Survey of the Human Gastric Ecosystem Using Culturing and Pyrosequencing Methods
Delgado, S., Cabrera‐Rubio, R., Mira, Á., Suárez, A., & Mayo, B. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0192-5 · Cited by 227
Review article: proton pump inhibitors and bacterial overgrowth
Williams, C., & McColl, K. E. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 219
McDonald, E. G., Milligan, J., Frenette, C., & Lee, T. C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.42 · Cited by 216
Safety of Proton Pump Inhibitor Exposure
Yang, Y., & Metz, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.023 · Cited by 211
The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome
Freedberg, D. E., Lebwohl, B., & Abrams, J. A. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.08.008 · Cited by 199
Review article: current treatment options and management of functional dyspepsia
Lacy, B. E., Talley, N. J., Locke, G. R., Bouras, E. P., DiBaise, J. K., El‐Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., & Prather, C. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05128.x · Cited by 192
Diagnosis of Helicobacter pylori Infection
Dzierżanowska‐Fangrat, K., Lehours, P., Mégraud, F., & Dzierzanowska, D. (2006) · Helicobacter · doi:10.1111/j.1478-405x.2006.00423.x · Cited by 177
Amir, I., Konikoff, F. M., Oppenheim, M., Gophna, U., & Half, E. E. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12285 · Cited by 176
Sanduleanu, S., Jonkers, D. M. A. E., A, A. P. D. B., Hameeteman, W. M., & Stockbrügger, R. W. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00888.x · Cited by 171
Survival in hostile territory: the microbiota of the stomach
Yang, I., Nell, S., & Suerbaum, S. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12027 · Cited by 168
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
Clooney, A. G., Bernstein, C. N., Leslie, W. D., Vagianos, K., Sargent, M., Laserna‐Mendieta, E. J., Claesson, M. J., & Targownik, L. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13568 · Cited by 166
Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
Tsuda, A., Suda, W., Morita, H., Takanashi, K., Takagi, A., Koga, Y., & Hattori, M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.20 · Cited by 164
Helicobacter pylori and the gastric microbiota
Engstrand, L. G., & Lindberg, M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.016 · Cited by 164
The Effect of Proton Pump Inhibitors on the Human Microbiota
Vesper, B. J., Jawdi, A., Altman, K. W., Haines, G. K., Tao, L., & Radosevich, J. A. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048392 · Cited by 145
Rosen, R., Hu, L., Amirault, J. P., Khatwa, U., Ward, D. V., & Onderdonk, A. B. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.067 · Cited by 105
Walker, M. M., & Talley, N. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12666 · Cited by 103
Kelly, O., Dillane, C., Patchett, S. E., Harewood, G. C., & Murray, F. E. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3642-8 · Cited by 80
Rolig, A. S., Cech, C., Ahler, E., Carter, J. E., & Ottemann, K. M. (2013) · Infection and Immunity · doi:10.1128/iai.00044-13 · Cited by 77
Talley, N. J., Holtmann, G., & Walker, M. M. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1076-x · Cited by 75
Participation of microbiota in the development of gastric cancer
Wang, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i17.4948 · Cited by 73
Diagnosis of Helicobacter pylori Infection
McNulty, C. A. M., Lehours, P., & Mégraud, F. (2011) · Helicobacter · doi:10.1111/j.1523-5378.2011.00875.x · Cited by 52
Helicobacter pylori and functional dyspepsia: an unsolved issue?
Zullo, A., Hassan, C., Francesco, V. D., Repici, A., Manta, R., Tomao, F., Annibale, B., & Vaira, D. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8957 · Cited by 35
Piano, M. D., Pagliarulo, M., Tari, R., Carmagnola, S., Balzarini, M., Lorenzini, P., & Pane, M. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000256 · Cited by 23
Boardman, H., Delaney, B. C., & Haag, S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1047745 · Cited by 23
Helicobacter pylori and functional dyspepsia: An unsolved issue?
Istituto, I. (2014) · Cited by 22
Ford, A. C., & Moayyedi, P. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328365d45d · Cited by 21
Shin, J. M., Munson, K. B., & Sachs, G. M. (2011) · Comprehensive physiology · doi:10.1002/cphy.c110010 · Cited by 20
Diagnosis of H elicobacter pylori Infection
Mégraud, F., Bessède, E., & Lehours, P. (2014) · Helicobacter · doi:10.1111/hel.12161 · Cited by 17
Current management of functional dyspepsia: impact of Rome III subdivision.
Karamanolis, G. P., & Tack, J. F. (2012) · PubMed · Cited by 14
Cited by
Sorted by citations
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Novel concepts in the pathophysiology and treatment of functional dyspepsia
Wauters, L. I., Talley, N. J., Walker, M. M., Tack, J. F., & Vanuytsel, T. (2019) · Gut · doi:10.1136/gutjnl-2019-318536 · Cited by 231
Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
Ticinesi, A., Milani, C., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G. A., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10734-y · Cited by 211
Parsons, B. N., Ijaz, U. Z., D’Amore, R., Burkitt, M. D., Eccles, R., Lenzi, L., Duckworth, C. A., Moore, A. R., Tiszlavicz, L., Varro, A., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006653 · Cited by 210
British Society of Gastroenterology guidelines on the management of functional dyspepsia
Black, C. J., Paine, P., Agrawal, A., Aziz, I., Eugenicos, M. P., Houghton, L. A., Hungin, P., Overshott, R., Vasant, D. H., Rudd, S., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327737 · Cited by 216
Metadata
- Authors
- Paroni Sterbini, F., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, W., Gasbarrini, A., Sanguinetti, M., Cammarota, G., & Posteraro, B.
- Affiliations
- Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy
- Università Cattolica del Sacro Cuore (IT)
- Biotechnologisches Zentrum (DE)
- ORCID
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-11-15
- Volume
- 82
- Issue
- 22
- Pages
- 6633-6644
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- PMC
- PMC5086557
- OpenAlex
- W2517918142
- Cited by
- 108
- References
- 60
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 6 · 2017: 8
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Applied and Environmental Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università Cattolica del Sacro Cuore (Linea D1, Linea D3.2-2013)
- Technische Universität Dresden
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- proton pump inhibitors, omeprazole, dyspepsia, gastric microbiota, Helicobacter pylori infection, Streptococcus, Streptococcaceae, Firmicutes, Helicobacter, dyspepsia treatment
- MeSH terms
- Firmicutes, Bacillota, Gastrointestinal Microbiome, Adult, Aged, Anti-Bacterial Agents, Bacteria, Dyspepsia, Female, Gastric Mucosa, Humans, Middle Aged, Omeprazole, RNA, Ribosomal, 16S, Streptococcus, Helicobacter pylori, Helicobacter Infections, Genes, rRNA, Proteobacteria, Bacteroidetes, Proton Pump Inhibitors, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
